|
|
Fate Therapeutics
company
|
Overview
Fate Therapeutics is developing proprietary induced pluripotent stem cell (iPSC) technology. The first clinical candidate entered clinical trials in early 2009 for hematopoietic stem cell support.
Financial Information
Areas of Expertise
Technologies involved in:
Induced Pluripotent Stem Cell,
Stem cell,
add other
Medical focus:
Corporate Information
Products
Therapeutics on the Market
| Product |
Developed By |
2007 Sales ($M) |
2006 Sales ($M) |
2005 Sales ($M) |
Indications / Phase of Development |
Products on the Market
| Product Brand |
Name |
Developed By |
2007 Sales ($M) |
Therapeutics in Development
| Product |
Developed By |
Indications / Phase of Development |
Products in Development
| Product |
Brand Name |
Overview |
